RVMD insider trading — Revolution Medicines, Inc.
No open-market insider purchases or sales were filed for Revolution Medicines, Inc. (RVMD) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent RVMD insider transactions
Every Form 4 filed by Revolution Medicines, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Sandler Alan B. | Chief Development Officer | M · Option exercise · 10b5-1 | Direct | 6,000 | $58.84 | $353K | Form 4 |
| Sep 29, 2026 | Sandler Alan B. | Chief Development Officer | S · Sale · 10b5-1 | Direct | 6,309 | $202.14 | $1.28M | Form 4 |
| Sep 25, 2026 | Cislini Jeff | SVP & General Counsel | S · Sale · 10b5-1 | Direct | 765 | $207.32 | $159K | Form 4 |
| Sep 25, 2026 | Mancini Anthony | See Remarks | M · Option exercise · 10b5-1 | Direct | 3,121 | $33.62 | $105K | Form 4 |
| Sep 25, 2026 | Mancini Anthony | See Remarks | S · Sale · 10b5-1 | Direct | 3,121 | $200.54 | $626K | Form 4 |
| Sep 24, 2026 | Mancini Anthony | See Remarks | S · Sale · 10b5-1 | Direct | 587 | $200.00 | $117K | Form 4 |
| Sep 22, 2026 | Anderson Elizabeth M | Director | M · Option exercise · 10b5-1 | Direct | 5,070 | $1.12 | $6K | Form 4 |
| Sep 22, 2026 | Anderson Elizabeth M | Director | S · Sale · 10b5-1 | Direct | 10,143 | $193.04 | $1.96M | Form 4 |
| Sep 18, 2026 | Mancini Anthony | See Remarks | S · Sale · 10b5-1 | Direct | 1,764 | $196.94 | $347K | Form 4 |
| Sep 16, 2026 | Sandler Alan B. | Chief Development Officer | S · Sale · 10b5-1 | Direct | 341 | $199.24 | $68K | Form 4 |
| Sep 16, 2026 | Mancini Anthony | See Remarks | S · Sale · 10b5-1 | Direct | 1,774 | $199.24 | $353K | Form 4 |
| Sep 16, 2026 | Kelsey Stephen Michael | See Remarks | S · Sale · 10b5-1 | Direct | 5,569 | $199.24 | $1.11M | Form 4 |
| Sep 16, 2026 | Horn Margaret A | Chief Operating Officer | S · Sale · 10b5-1 | Direct | 4,967 | $199.24 | $990K | Form 4 |
| Sep 16, 2026 | Goldsmith Mark A | See Remarks | S · Sale · 10b5-1 | Direct | 13,988 | $199.24 | $2.79M | Form 4 |
| Sep 16, 2026 | Cislini Jeff | SVP & General Counsel | S · Sale · 10b5-1 | Direct | 3,366 | $199.24 | $671K | Form 4 |
| Sep 16, 2026 | Anders Jack | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 4,053 | $199.24 | $808K | Form 4 |
| Sep 11, 2026 | Kelsey Stephen Michael | See Remarks | M · Option exercise · 10b5-1 | Direct | 92,531 | $41.71 | $3.86M | Form 4 |
| Sep 11, 2026 | Kelsey Stephen Michael | See Remarks | S · Sale · 10b5-1 | Direct | 92,531 | $202.36 | $18.72M | Form 4 |
| Sep 10, 2026 | Mancini Anthony | See Remarks | M · Option exercise · 10b5-1 | Direct | 9,363 | $33.62 | $315K | Form 4 |
| Sep 10, 2026 | Mancini Anthony | See Remarks | S · Sale · 10b5-1 | Direct | 15,448 | $204.16 | $3.15M | Form 4 |
| Sep 8, 2026 | Kim Lorence H. | Director | S · Sale · 10b5-1 | Indirect | 17,090 | $209.82 | $3.59M | Form 4 |
| Aug 31, 2026 | Kim Lorence H. | Director | S · Sale · 10b5-1 | Indirect | 56,000 | $203.24 | $11.38M | Form 4 |
| Aug 21, 2026 | Goldsmith Mark A | See Remarks | M · Option exercise · 10b5-1 | Direct | 80,000 | $4.73 | $378K | Form 4 |
| Aug 21, 2026 | Goldsmith Mark A | See Remarks | S · Sale · 10b5-1 | Direct | 80,000 | $209.20 | $16.74M | Form 4 |
| Aug 21, 2026 | Goldsmith Mark A | See Remarks | S · Sale · 10b5-1 | Indirect | 6,000 | $209.20 | $1.26M | Form 4 |
| Aug 21, 2026 | Cislini Jeff | General Counsel | M · Option exercise · 10b5-1 | Direct | 56,280 | $20.00 | $1.13M | Form 4 |
| Aug 21, 2026 | Cislini Jeff | General Counsel | S · Sale · 10b5-1 | Direct | 56,894 | $209.24 | $11.90M | Form 4 |
RVMD insider trading FAQ
Are insiders buying RVMD stock?
Not on the open market. In the last 90 days, Revolution Medicines, Inc. insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading RVMD?
No insider bought or sold on the open market in the last 90 days.
Where does RVMD insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.